FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1387-1388 May 7, 1998 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Becquemin, J.-P. PubMed Citation

To the Editor: Becquemin (Dec. 11 issue) ¹ reports the results of a randomized, prospective study demonstrating the improved patency of infrainguinal-vein bypass grafts in patients treated with the antiplatelet agent ticlopidine as compared with placebo. The data appear to demonstrate an important effect and to confirm a widely held belief that properly administered antiplatelet therapy promotes the patency of vascular reconstructions.

Several factors, however, may limit widespread application of these findings. First, it should be noted that the patency rates in the placebo group were significantly inferior to those reported in single-institution studies at high-volume centers. In general, the current . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Heckenkamp, J., Lamuraglia, G. M. (1999). Intimal Hyperplasia, Arterial Remodeling, and Restenosis: An Overview. PERSPECT VASC SURG ENDOVASC THER 11: 71-94 [Abstract]